Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Current Deferred Revenue (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Current Deferred Revenue for 16 consecutive years, with $9.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue fell 82.3% to $9.7 million in Q3 2025 year-over-year; TTM through Aug 2025 was $9.7 million, a 82.3% decrease, with the full-year FY2024 number at $56.3 million, up 10.72% from a year prior.
  • Current Deferred Revenue was $9.7 million for Q3 2025 at Cryo Cell International, up from $9.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $56.3 million in Q4 2024 to a low of $9.3 million in Q1 2023.
  • A 5-year average of $34.5 million and a median of $40.6 million in 2021 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: surged 467.47% in 2024, then tumbled 82.3% in 2025.
  • Cryo Cell International's Current Deferred Revenue stood at $40.6 million in 2021, then rose by 12.19% to $45.6 million in 2022, then grew by 11.64% to $50.9 million in 2023, then grew by 10.72% to $56.3 million in 2024, then crashed by 82.71% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Current Deferred Revenue are $9.7 million (Q3 2025), $9.4 million (Q1 2025), and $56.3 million (Q4 2024).